Cost-Effectiveness of Celecoxib and Non Selective Non Steroidal Anti-Inflammatory Drug (Nsaid) Therapy for the Treatment of Osteoarthritis in Spain: A Decision-Tree Model

Value Health. 2014 Nov;17(7):A379-80. doi: 10.1016/j.jval.2014.08.2610. Epub 2014 Oct 26.

Authors

Lossada Juste A De¹, Gutiérrez J Rejas², Álvaro Á Oteo³

Affiliations

¹ Pfizer, S. L. U, Alcobendas/Madrid, Spain.
² Pfizer S. L. U., Alcobendas/Madrid, Spain.
³ Hospital General Universitario Gregorio Marañón, Madrid, Spain.

PMID: 27200836
DOI: 10.1016/j.jval.2014.08.2610

No abstract available